Medicine and Dentistry
Cardiovascular Disease
100%
Low Density Lipoprotein Cholesterol
61%
Statin
53%
Atherosclerosis
49%
Cardiovascular System
41%
Isotopes of Calcium
41%
Digital Health
38%
Clinician
38%
Cardiovascular Risk
38%
Mobile Health
38%
Lipoprotein
35%
Cardiovascular Disease Prevention
34%
Disease
34%
Coronary Artery
33%
Dyslipidemia
26%
Primary Prevention
25%
Health Technology
25%
Diabetes
24%
Apoplexy
24%
High Density Lipoprotein Cholesterol
23%
Triacylglycerol
23%
Drug Therapy
21%
Blood Pressure
20%
Myocardial Infarction
20%
Acute Heart Infarction
19%
Prevalence
19%
Heart Rehabilitation
18%
Physical Activity
18%
Familial Hypercholesterolemia
17%
Systematic Review
16%
Heart Disease
16%
Secondary Prevention
12%
Heart Failure
12%
Cardiology
11%
Ischemic Heart Disease
11%
Apolipoprotein B
11%
Personalized Medicine
11%
Insulin Resistance
10%
C Reactive Protein
10%
Randomized Controlled Trial
10%
Coronary Artery Calcification
9%
Health Care Cost
9%
Biological Marker
9%
Cross Sectional Study
9%
High-Density Lipoprotein
9%
Clinical Trial
9%
Meta-Analysis
9%
Preventive Cardiology
9%
Hazard Ratio
8%
Risk Reduction
8%
Keyphrases
Low-density Lipoprotein Cholesterol (LDL-C)
76%
Lipids
52%
Statins
46%
Cardiovascular Disease
45%
Cardiovascular Risk
36%
Atherosclerotic Cardiovascular Disease (ASCVD)
32%
Coronary Artery Calcium
31%
Lipoproteins
31%
High-density Lipoprotein Cholesterol (HDL-C)
29%
Statin Therapy
28%
Multi-Ethnic Study of Atherosclerosis
26%
Cholesterol
25%
Large Database
25%
United States
24%
Dyslipidemia
24%
Non-high-density Lipoprotein Cholesterol (non-HDL-C)
23%
Apolipoprotein B (Apo B)
22%
Meta-analysis
21%
Confidence Interval
20%
Cardiovascular Prevention
19%
Triglycerides
18%
Systematic Meta-analysis
17%
Primary Prevention
15%
Heart Disease
15%
Lipid Biomarkers
14%
Cardiovascular Health
14%
MHealth
13%
Risk Factors
13%
Acute Myocardial Infarction
13%
Digital Health Intervention
13%
Heart Stroke
13%
Physical Activity
12%
Lipid-lowering Therapy
12%
Coronary Artery Calcification
12%
Diabetes
11%
Homozygous Familial Hypercholesterolemia (HoFH)
11%
Precision Medicine
11%
Preventive Cardiology
11%
Statin Use
11%
Secondary Prevention
11%
Randomized Controlled Trial
11%
LDL Cholesterol
11%
Atherosclerotic Cardiovascular Disease Risk
10%
Cardiac Rehabilitation
10%
Disease Statistics
10%
Stroke Index
10%
Coronary Artery Disease
10%
Friedewald
10%
Remnant Lipoprotein Cholesterol
10%
Subclinical Atherosclerosis
10%
Pharmacology, Toxicology and Pharmaceutical Science
Low Density Lipoprotein Cholesterol
90%
Statin (Protein)
71%
Cardiovascular Disease
51%
Coronary Artery Atherosclerosis
51%
Lipoprotein
44%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
42%
High Density Lipoprotein Cholesterol
39%
Triacylglycerol
38%
Atherosclerosis
32%
Cardiovascular Risk
31%
Heart Infarction
21%
Lipoprotein A
20%
Dyslipidemia
20%
Prevalence
16%
Apolipoprotein B
16%
Disease
15%
Low Density Lipoprotein
15%
Randomized Controlled Trial
14%
Ischemic Heart Disease
14%
C Reactive Protein
13%
High Density Lipoprotein
12%
Very Low Density Lipoprotein
11%
Adverse Event
10%
Acute Heart Infarction
10%
HIV
10%
Proprotein Convertase 9
9%
Biological Marker
9%
Vitamin D
9%
Familial Hypercholesterolemia
8%
Inflammation
8%
Symptom
8%
Placebo
8%
Clinical Trial
7%
Hyperlipoproteinemia Type 3
7%
Acute Coronary Syndrome
7%
Hypercholesterolemia
7%
Diabetes Mellitus
6%
Coronary Artery Calcification
6%
Atrial Fibrillation
6%
Cohort Study
6%
Heart Failure
6%
Thyroid Disease
5%
Myopathy
5%
Simvastatin
5%
Intermediate Density Lipoprotein
5%
Evolocumab
5%
Non Insulin Dependent Diabetes Mellitus
5%
Alirocumab
5%
Pitavastatin
5%
Insulin Resistance
5%
